The Revolutionizing Impact of Artificial Intelligence on Breast Cancer Management
Abstract
NA
References
Deep learning [Available from: https://en.wikipedia.org/wiki/Deep_learning.
Yang P, Abo R, Liu C, Chen Z, Wu H, et al. Novel feature selection strategies for enhanced predictive modeling and deep learning in the biosciences. AACR; 2017.
Wang D, Li J-R, Zhang Y-H, Chen L, Huang T, et al. Identification of differentially expressed genes between original breast cancer and xenograft using machine learning algorithms. Genes. 2018;9(3):155.
Caravagna G, Giarratano Y, Ramazzotti D, Tomlinson I, Graham TA, et al. Detecting repeated cancer evolution from multi-region tumor sequencing data. Nat Methods. 2018;15(9):707-14.
Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, et al. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep. 2018;23(1):172-80 e3.
Li J, Chen L, Zhang YH, Kong X, Huang T, et al. A Computational Method for Classifying Different Human Tissues with Quantitatively Tissue-Specific Expressed Genes. Genes (Basel). 2018;9(9).
Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, et al. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018;24(24):6288-99.
Allen D. AI Could Revolutionize Gene Therapy 2018 [Available from: http://emag.medicalexpo.com/ai-could-revolutionize-gene-therapy/.
Project TUGROVIS – Tumor-Growth Machine Learning 2015 [Available from: https://hci-kdd.org/project/tumor-growth-machine-learning/.
Afzali F, Akbari P, Naderi-Manesh H, Gardaneh M. The Next Generation Personalized Models to Screen Hidden Layers of Breast Cancer Tumorigenicity. Breast Cancer Res Treat 2019.
Toratani M, Konno M, Asai A, Koseki J, Kawamoto K, et al. A convolutional neural network uses microscopic images to differentiate between mouse and human cell lines and their radioresistant clones. Cancer research. 2018;78(23):6703-7.
Preuer K, Lewis RP, Hochreiter S, Bender A, Bulusu KC, et al. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning. Bioinformatics. 2017;34(9):1538-46.
ubidecarenone nanodispersion BPM31510 [Available from: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510.
Samala RK, Chan HP, Hadjiiski L, Helvie MA, Wei J, et al. Mass detection in digital breast tomosynthesis: Deep convolutional neural network with transfer learning from mammography. Med Phys. 2016;43(12):6654.
Lehman CD, Yala A, Schuster T, Dontchos B, Bahl M, et al. Mammographic breast density assessment using deep learning: clinical implementation. Radiology. 2018;290(1):52-8.
Bejnordi BE, Veta M, Van Diest PJ, Van Ginneken B, Karssemeijer N, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. Jama. 2017;318(22):2199-210.
Authors
Copyright (c) 2019 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.
